TY  - GEN 
AU  - Geribaldi Doldán, Noelia
AU  - Hervás-Corpión, Irati
AU  - Gómez Oliva, Ricardo
AU  - Domínguez García, Samuel
AU  - Ruiz Rodríguez, Félix Alejandro
AU  - Iglesias Lozano, Silvia
AU  - Carrascal, Livia
AU  - Pardillo Díaz, Ricardo
AU  - Gil-Salú, José L.
AU  - Nunez Abades, Pedro
AU  - Valor, Luis M.
AU  - Castro González, Carmen
A4  - Biomedicina, Biotecnología y Salud Pública
A4  - Cirugía
PY  - 2021
SN  - 2227-9059
UR  - http://hdl.handle.net/10498/24947
AB  - Glioblastoma (GBM) is the most frequent and aggressive primary brain tumor and is associated with a poor prognosis. Despite the use of combined treatment approaches, recurrence is almost inevitable and survival longer than 14 or 15 months after...
LA  - eng
PB  - MDPI
KW  - glioblastoma
KW  - protein kinase C
KW  - glioma stem cells
KW  - neurogenesis
KW  - neural stem cells
KW  - temozolomide
KW  - enzastaurin
KW  - epidermal growth factor receptor
KW  - neuregulin
TI  - Targeting Protein Kinase C in Glioblastoma Treatment
DO  - 10.3390/biomedicines9040381
ER  -